Company intelligence / Profile preview

Universal Ibogaine Inc.

Calgary, Alberta, Canadauniversalibogaine.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Universal Ibogaine Inc. aims to transform addiction recovery by developing and operating clinics that utilize ibogaine—a naturally occurring psychedelic compound—as part of an evidence-based, holistic treatment program. The company’s safety protocol has reportedly aided over 3,700 people with zero fatalities related to ibogaine administration at its research partner clinic. Clinical trials are being pursued in Canada to further medicalize and validate this approach for broader adoption[1].

Therapeutic areas: Psychiatry
Modalities: Psychedelic small molecule (ibogaine)
Industry: Biotech

Drug pipeline

1 asset

ibogaine

Pre-clinical

Indications: Opioid use disorder, Addiction

Partnerships

Research partner clinic with established safety protocol for ibogaine administration (>3700 patients treated)[1]. No major pharmaceutical partnerships disclosed.

Beyond the preview

Go deeper on Universal Ibogaine Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Universal Ibogaine Inc..

Explore the full profile